Pluvia – Giving PKU patients a shot at normal life
1 in 10 000 children will be affected by phenylketonuria (PKU), a rare genetic disorder caused by protein misfolding. The disease prevents patients to process food normally, causing the build up of toxic compounds in the body. Pluvia, an academic spin-out based on research from the University of Bergen, is developing a new treatment for PKU to help PKU patients living a normal life.
Read more